Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Schizophr Res. 2015 Jun 20;166(0):219–224. doi: 10.1016/j.schres.2015.06.002

Table 4. N-acetylglucosaminyltransferase expression in schizophrenia and comparison subjects.

Enzyme Schizophrenia Comparison t p
MGAT1 0.021± 0.017 0.014 ± 0.010 1.69
MGAT4A 5.669 ± 4.907 7.941 ± 6.040 2.66 0.022
MGAT4B 0.004 ± 0.006 0.004 ± 0.003 0.31
MGAT4C 0.027 ± 0.029 0.024 ± 0.014 0.3
MGAT5 0.003 ± 0.002 0.002 ± 0.001 0.55
MGAT5B 1.127 ± 1.041 1.691 ± 2.365 0.96
B3GNT2 4.172 ± 4.350 4.641 ± 4.134 0.66
B3GNT3 0.009 ± 0.005 0.009 ± 0.004 0.01
B3GNT8 44.53 ± 68.46 153.52 ± 192.76 2.58 0.025

Data are expressed as ratios of signal intensity of target protein divided by signal for VCP, and reported as means ± standard deviation.